Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Cheng

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Critical Care Explorations|May 30, 2025
Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired PneumoniaGeorge S Chen, Terry Lee, Jennifer L Y Tsang, et al.
NPJ Vaccines|November 9, 2022
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without ComorbiditiesNathalie Charland, Philipe Gobeil, Stéphane Pillet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old FoeSteven Y C Tong, Jocelyn Mora, Asha C Bowen, et al.
Pneumonia (Nathan Qld.)|November 24, 2024
Community versus academic hospital community-acquired pneumonia patients: a nested cohort studyJennifer L Y Tsang, Kian Rego, Alexandra Binnie, et al.
Plos Medicine|November 10, 2022
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studiesIsabel Bergeri, Mairead G Whelan, Harriet Ware, et al.
Critical Reviews in Microbiology|January 11, 2019
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope<sup>®</sup>Danila Seidel, Arne Meißner, Michaela Lackner, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Open Forum Infectious Diseases|November 18, 2020
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Critical Care Medicine|May 24, 2022
Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19Genevieve L Y Rocheleau, Terry Lee, Yassene Mohammed, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2019
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)Jon Salmanton-García, Danila Seidel, Philipp Koehler, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Critical Care Explorations|May 30, 2025
Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired PneumoniaGeorge S Chen, Terry Lee, Jennifer L Y Tsang, et al.
NPJ Vaccines|November 9, 2022
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without ComorbiditiesNathalie Charland, Philipe Gobeil, Stéphane Pillet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old FoeSteven Y C Tong, Jocelyn Mora, Asha C Bowen, et al.
Pneumonia (Nathan Qld.)|November 24, 2024
Community versus academic hospital community-acquired pneumonia patients: a nested cohort studyJennifer L Y Tsang, Kian Rego, Alexandra Binnie, et al.
Plos Medicine|November 10, 2022
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studiesIsabel Bergeri, Mairead G Whelan, Harriet Ware, et al.
Critical Reviews in Microbiology|January 11, 2019
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope<sup>®</sup>Danila Seidel, Arne Meißner, Michaela Lackner, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Open Forum Infectious Diseases|November 18, 2020
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Critical Care Medicine|May 24, 2022
Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19Genevieve L Y Rocheleau, Terry Lee, Yassene Mohammed, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2019
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)Jon Salmanton-García, Danila Seidel, Philipp Koehler, et al.
Pageof 16